News

All news

2019-05-20

ACCORD HEALTHCARE LAUNCH FEBUXOSTAT 80 & 120 MG FILM COATED TABLETS

Accord Healthcare is delighted to announce the launch of Febuxostat 80 & 120 mg which are available in pack sizes of 28 Film Coated Tablets.

This medicine is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).  Febuxostat Accord is indicated in adults.

Please refer to the Summary of Product Characteristics (SPC) available here. 

All news